From breakthrough to patient
Faster, Affordable, Smarter, Together
We close the gaps in antibody development
Bringing to the market new therapeutic protein and antibody breakthroughs is often severely hindered by the lack of accessible infrastructure and critical gaps in available expertise.
We partner with you to lower the threshold for phase 0/1 clinical trials, shorten developmental timelines and reduce risk.
Scroll down to find out how.
What we stand for
Our mission is to transform antibody and protein therapeutics development through innovative, standardized, and scalable processing solutions, eliminating CMC barriers and fast-tracking life-changing therapies to patients. Our efficient and scalable development platform, reduces time-to-clinic from years to months across the global biotechnology ecosystem.
patient impact ABOVE ALL
Everything we develop we ultimately measure by one outcome: enabling therapies that improve and save lives
Partnership + transparency
We believe in open communication, shared goals, and seamless collaboration with clients and partners.
Science-led innovation
We push the boundaries of antibody development through smarter, scalable, and standardized technologies.
Speed with INTEGRITY
We move fast without compromising scientific rigor, compliance, or data quality.
Accessibility + afFordability
We lower barriers to CMC development so promising therapies - big or small - can reach the clinic.
reliability and Quality
We deliver consistent, high-quality results that innovators can trust at every step.